Stock Analysts’ Updated EPS Estimates for August, 16th (BYPLF, CALM, CBTX, CHCO, CHMA, CHU, CLRB, CPCAY, CPLG, CRAWA)

   2019-08-17 01:08

Stock Analysts’ updated eps estimates for Friday, August 16th:

Bodycote (OTCMKTS:BYPLF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Bodycote PLC provides thermal processing services through heat treatment, metal joining, surface technology and Hot Isostatic Pressing. It serves aerospace, defense, automotive, power generation, oil & gas, construction, medical and transportation industry. Bodycote PLC is headquartered in Macclesfield, the United Kingdom. “



Cal-Maine Foods (NASDAQ:CALM) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Cal-Maine Foods, Inc. is primarily engaged in the production, grading, packing and sale of fresh shell eggs, including conventional, cage-free, organic and nutritionally-enhanced eggs. The Company, which is headquartered in Jackson, Mississippi, is the largest producer and distributor of fresh shell eggs in the United States and sells the majority of its shell eggs in states across the southwestern, southeastern, mid-western and mid-Atlantic regions of the United States. “

CBTX (NASDAQ:CBTX) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CBTX, Inc. is a bank holding company. It provides personal and commercial banking, real estate loans, and investment services as well as offers deposits, debit and credit cards, cash management, treasury, and online banking services. CBTX, Inc. is based in TX, United States. “

City (NASDAQ:CHCO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “City Holding Company is a multi-bank holding company that provides diversified financial products and services to consumers and local businesses. “

Chiasma (NASDAQ:CHMA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $5.50 target price on the stock. According to Zacks, “Chiasma, Inc. is a biopharmaceutical company. The company’s TPE(R) technology develops oral peptides and other molecules. Its primary product candidate consists of oral octreotide which is in different clinical trial. Chiasma, Inc. is based in Newton, USA. “

China Unicom (Hong Kong) (NYSE:CHU) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “China Unicom Limited is engaged in the provision of cellular, paging, long distance, data and internet services in the People’s Repulic of China. “

Cellectar Biosciences (NASDAQ:CLRB) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $2.25 target price on the stock. According to Zacks, “Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. “

CATHAY PAC AIRW/S (OTCMKTS:CPCAY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “CATHAY PACIFIC AIRWAY’s principal activity is the operation of an international airline based and registered in Hong Kong. Other activities include airline catering, aircraft handling and engineering. The Group offers scheduled passenger and cargo services to 62 destinations around the world. It operates in Hong Kong, Mainland China, Japan, Korea, Taiwan, South East Asia, Middle East, Europe, Pacific and South Africa. “

CorePoint Lodging (NYSE:CPLG) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Corepoint Lodging Inc is a real-estate investment trust. It focused on select-service midscale and upper-midscale lodging. The company owns a diverse portfolio of hotels. Corepoint Lodging Inc is based in Irving, United States. “

Crawford United (OTCMKTS:CRAWA) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. The firm currently has $22.00 target price on the stock. According to Zacks, “Crawford United Corporation develops and manufactures products for diverse markets. It primarily serves healthcare, education, automotive, aerospace, trucking and petrochemical industries. The company’s operating business segment consists of Aerospace Components, Commercial Air Handling and Industrial Hose. Crawford United Corporation, formerly known as Hickok Incorporated, is based in Cleveland, Ohio. “

Crinetics Pharmaceuticals (NASDAQ:CRNX) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Crinetics Pharmaceuticals Inc is a clinical stage pharmaceutical company. It focuses on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company’s product pipeline consists of CRN00808 for the treatment of Acromegaly, CRN02481 for the treatment of Hyperinsulinemias and CRN01941 for the treatment of Neuroendocrine Tumors which are in clinical stage. Crinetics Pharmaceuticals Inc is based in San Diego, United States. “

CubeSmart (NYSE:CUBE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “CubeSmart is a self-administered and self-managed real estate company focused on the ownership, operation, acquisition and development of self storage facilities in the United States. Its self storage facilities are designed to offer storage space for residential and commercial customers. CubeSmart, formally known as U-Store-It Trust, is based in Wayne, Pennsylvania. “

COLRUYT SA/ADR (OTCMKTS:CUYTY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Colruyt SA engages in the retail and distribution of food and non-food products as well as fuels. Its operating segment includes Retail, Wholesale and Food Service, and Other Activities. Retail segment includes stores under the management that directly supplies retail customers and bulk consumers. Wholesale and Food Service segment supplies wholesalers, bulk customers, and affiliated independent merchants. Other Activities segment includes businesses such as filling stations, printing and document management and alternative energy. Colruyt SA is headquartered in Halle, Belgium. “

Cyclacel Pharmaceuticals (NASDAQ:CYCC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CYCLACEL is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Three orally-available Cyclacel drugs are in clinical development. Sapacitabine, a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and cutaneous T-cell lymphoma. Seliciclib (CYC202 or R-roscovitine), a CDK inhibitor, is in Phase 2 for the treatment of lung cancer and nasopharyngeal cancer. “

China Yuchai International (NYSE:CYD) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “China Yuchai International Ltd is involved in the Automotive Industry. They manufacture medium-duty diesel engines in China. They also produce diesel power generators and diesel engine parts. The Company primarily manufactures and sells diesel engines for medium-duty trucks in China. “

Danone (OTCMKTS:DANOY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $20.00 price target on the stock. According to Zacks, “Danone SA is engaged in food processing activities primarily in France and internationally. The Company operates in four business lines: Fresh Dairy Products, Waters, Baby Nutrition, and Medical Nutrition. The Fresh Dairy Products division produces and markets yogurts, fermented fresh dairy products, and other specialized fresh dairy products .The Waters division produces and distributes packaged natural, flavored, and vitamin-enriched water. The Baby Nutrition division provides food for infants and toddlers to complement breast-feeding. The Medical Nutrition division offers products to treat disease-related to malnutrition. Danone SA, formerly known as Groupe Danone, is based in Paris, France. “

Receive News & Ratings for Bodycote PLC Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bodycote PLC and related companies with MarketBeat.com’s FREE daily email newsletter.


Original Source